Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy.
NLR
NSCLC
PD-L1
TILs
TMB
concomitant medications
gut microbiota
immunotherapy
prognostic factors
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
22 Sep 2023
22 Sep 2023
Historique:
received:
01
08
2023
revised:
13
09
2023
accepted:
19
09
2023
medline:
14
10
2023
pubmed:
14
10
2023
entrez:
14
10
2023
Statut:
epublish
Résumé
Taking into account the huge epidemiologic impact of lung cancer (in 2020, lung cancer accounted for 2,206,771 of the cases and for 1,796,144 of the cancer-related deaths, representing the second most common cancer in female patients, the most common cancer in male patients, and the second most common cancer in male and female patients) and the current lack of recommendations in terms of prognostic factors for patients selection and management, this article aims to provide an overview of the current landscape in terms of currently available immunotherapy treatments and the most promising assessed prognostic biomarkers, highlighting the current state-of-the-art and hinting at future challenges.
Identifiants
pubmed: 37835378
pii: cancers15194684
doi: 10.3390/cancers15194684
pmc: PMC10571734
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Front Oncol. 2021 Apr 29;11:672677
pubmed: 33996601
N Engl J Med. 2018 Jun 14;378(24):2288-2301
pubmed: 29863955
J Natl Cancer Inst. 2014 May 29;106(6):dju124
pubmed: 24875653
Sci Rep. 2021 Oct 5;11(1):19712
pubmed: 34611279
Surg Clin North Am. 2022 Jun;102(3):335-344
pubmed: 35671760
Cancer Sci. 2014 Feb;105(2):159-67
pubmed: 24289533
Cancer. 2020 Feb 1;126(3):575-582
pubmed: 31648379
EMBO J. 1994 Sep 1;13(17):3992-4001
pubmed: 8076595
Br J Cancer. 2023 Feb;128(3):451-458
pubmed: 36564565
Ther Adv Med Oncol. 2021 Feb 27;13:1758835921996656
pubmed: 33717227
Blood. 2011 Apr 28;117(17):4501-10
pubmed: 21385853
J Immunol. 2010 Dec 15;185(12):7223-34
pubmed: 21076066
Medicine (Baltimore). 2019 Jun;98(26):e16238
pubmed: 31261584
Respir Investig. 2022 Mar;60(2):234-240
pubmed: 34972681
Cancers (Basel). 2021 Feb 16;13(4):
pubmed: 33669271
J Thorac Oncol. 2017 May;12(5):814-823
pubmed: 28132868
Tumour Biol. 2016 Oct;37(10):14083-14088
pubmed: 27511116
Front Oncol. 2017 Aug 28;7:193
pubmed: 28894699
Immunity. 2014 Oct 16;41(4):529-42
pubmed: 25367570
Support Care Cancer. 2015 Jun;23(6):1699-708
pubmed: 25430482
Lancet Oncol. 2021 Feb;22(2):198-211
pubmed: 33476593
Cytokine Growth Factor Rev. 2014 Apr;25(2):91-106
pubmed: 24484736
Adv Exp Med Biol. 2009;647:156-73
pubmed: 19760073
JAMA Oncol. 2018 Mar 01;4(3):351-357
pubmed: 29327044
J Immunother Cancer. 2021 Apr;9(4):
pubmed: 33827906
Transl Lung Cancer Res. 2019 Dec;8(6):1078-1085
pubmed: 32010585
J Cachexia Sarcopenia Muscle. 2021 Jun;12(3):657-664
pubmed: 33951326
Ann Med Surg (Lond). 2022 May 14;78:103752
pubmed: 35600176
J Immunother Cancer. 2019 Feb 27;7(1):57
pubmed: 30813970
J Exp Med. 2005 Oct 3;202(7):885-91
pubmed: 16186187
Clin Cancer Res. 2018 Apr 1;24(7):1562-1573
pubmed: 29203588
Curr Oncol. 2018 Aug;25(4):e324-e334
pubmed: 30111979
Cancer Diagn Progn. 2023 Jan 3;3(1):44-52
pubmed: 36632583
N Engl J Med. 2018 Nov 22;379(21):2040-2051
pubmed: 30280635
Front Pharmacol. 2023 Jan 24;14:1130562
pubmed: 36762108
Transl Lung Cancer Res. 2019 Aug;8(4):352-366
pubmed: 31555511
Anticancer Res. 2019 Mar;39(3):1455-1461
pubmed: 30842182
J Immunother Cancer. 2018 May 16;6(1):39
pubmed: 29769148
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Transl Lung Cancer Res. 2019 Dec;8(6):895-906
pubmed: 32010568
Clin Lung Cancer. 2018 Sep;19(5):410-417.e1
pubmed: 29859759
Cancers (Basel). 2019 Aug 29;11(9):
pubmed: 31470546
Am J Clin Oncol. 2016 Feb;39(1):98-106
pubmed: 26558876
J Immunother Cancer. 2019 Oct 26;7(1):278
pubmed: 31655605
Nat Med. 2022 Nov;28(11):2374-2380
pubmed: 36008722
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
BMC Cancer. 2020 Dec 3;20(1):1185
pubmed: 33272262
Cancer Res. 2014 Jul 1;74(13):3418-28
pubmed: 24769443
Cancer Res. 2014 Apr 1;74(7):1924-32
pubmed: 24691993
N Engl J Med. 2020 Oct 1;383(14):1328-1339
pubmed: 32997907
J Immunol. 2007 Dec 1;179(11):7365-75
pubmed: 18025180
N Engl J Med. 2016 Nov 10;375(19):1823-1833
pubmed: 27718847
J Thorac Oncol. 2016 Jul;11(7):964-75
pubmed: 27117833
Contemp Oncol (Pozn). 2021;25(1):45-52
pubmed: 33911981
J Exp Med. 2011 Mar 14;208(3):577-92
pubmed: 21383057
Lancet. 2021 Aug 7;398(10299):535-554
pubmed: 34273294
Cancer Discov. 2018 Sep;8(9):1069-1086
pubmed: 30115704
Curr Med Chem. 2019;26(17):3009-3025
pubmed: 28782469
Lung Cancer Manag. 2020 Apr 24;9(2):LMT31
pubmed: 32346405
J Immunol. 2006 Jul 15;177(2):1052-61
pubmed: 16818761
Mod Pathol. 2017 Dec;30(12):1666-1676
pubmed: 28776578
Ann Oncol. 2023 Apr;34(4):358-376
pubmed: 36669645
Med Oncol. 2018 Jan 31;35(3):25
pubmed: 29388007
Tumour Biol. 2017 May;39(5):1010428317698352
pubmed: 28475007
Eur J Immunol. 2004 Aug;34(8):2268-75
pubmed: 15259024
J Clin Pharmacol. 2016 Feb;56(2):157-69
pubmed: 26183909
Front Immunol. 2017 Dec 04;8:1597
pubmed: 29255458
Front Pharmacol. 2017 Aug 23;8:561
pubmed: 28878676
Tob Control. 2008 Jun;17(3):198-204
pubmed: 18390646
J Immunother Cancer. 2020 Oct;8(2):
pubmed: 33077515
Clin Cancer Res. 2023 Jul 14;29(14):2580-2587
pubmed: 36648402
J Natl Cancer Inst. 2015 Feb 03;107(3):
pubmed: 25650315
JAMA Oncol. 2021 Dec 01;7(12):1824-1832
pubmed: 34673888
Am J Med. 1980 Oct;69(4):491-7
pubmed: 7424938
N Engl J Med. 2018 May 31;378(22):2093-2104
pubmed: 29658845
J Immunother Cancer. 2018 Dec 27;6(1):157
pubmed: 30587233
J Biomed Sci. 2022 Feb 14;29(1):12
pubmed: 35164764
Eur J Immunol. 2015 Jul;45(7):1892-905
pubmed: 26018646
JTO Clin Res Rep. 2020 Mar 04;1(2):100020
pubmed: 34589927
J Clin Oncol. 2023 Feb 20;41(6):1213-1227
pubmed: 36327426
Lancet. 2001 Feb 17;357(9255):539-45
pubmed: 11229684
JAMA Netw Open. 2021 Mar 1;4(3):e213520
pubmed: 33779745
Int J Mol Sci. 2022 Mar 13;23(6):
pubmed: 35328510
Science. 2015 Nov 27;350(6264):1084-9
pubmed: 26541606
Cancers (Basel). 2022 Nov 02;14(21):
pubmed: 36358821
JAMA Oncol. 2020 Apr 1;6(4):512-518
pubmed: 31876896
Eur J Immunol. 2014 Sep;44(9):2703-2711
pubmed: 24838857
Cancer Immunol Immunother. 2022 Feb;71(2):387-398
pubmed: 34180007
J Pers Med. 2021 Oct 27;11(11):
pubmed: 34834454
Nat Rev Cancer. 2022 Dec;22(12):703-722
pubmed: 36253536
In Vivo. 2021 Nov-Dec;35(6):3423-3430
pubmed: 34697178
Mayo Clin Proc. 2008 May;83(5):584-94
pubmed: 18452692
J Immunol. 2004 Feb 1;172(3):1483-90
pubmed: 14734725
ESMO Open. 2017 Jul 3;2(2):e000213
pubmed: 28761757
Cancer Med. 2018 Dec;7(12):6124-6136
pubmed: 30403008
N Engl J Med. 2019 Nov 21;381(21):2020-2031
pubmed: 31562796
Transl Lung Cancer Res. 2020 Aug;9(4):967-970
pubmed: 32953477
Nat Med. 2019 Jan;25(1):141-151
pubmed: 30420753
Science. 2013 Nov 22;342(6161):971-6
pubmed: 24264990
N Engl J Med. 2018 May 31;378(22):2078-2092
pubmed: 29658856
Cancers (Basel). 2022 Dec 31;15(1):
pubmed: 36612290
Lancet Oncol. 2019 Jul;20(7):924-937
pubmed: 31122901
Cancers (Basel). 2020 Nov 25;12(12):
pubmed: 33255582
Vaccines (Basel). 2016 Jul 26;4(3):
pubmed: 27472371
Transl Lung Cancer Res. 2019 Jun;8(3):214-226
pubmed: 31367535
Science. 2018 Jan 5;359(6371):91-97
pubmed: 29097494
Front Immunol. 2020 Nov 19;11:595835
pubmed: 33324413
Br J Cancer. 2018 Oct;119(8):950-960
pubmed: 30318514
Oncoimmunology. 2018 Apr 20;7(8):e1452581
pubmed: 30221046
J Clin Oncol. 2022 Oct 1;40(28):3323-3343
pubmed: 35816668
Ther Adv Med Oncol. 2022 Jul 15;14:17588359221111703
pubmed: 35860836
Oncoimmunology. 2013 Apr 1;2(4):e23849
pubmed: 23734331
Cancer Res. 2014 Apr 1;74(7):1933-44
pubmed: 24691994
Nat Commun. 2016 Feb 17;7:10501
pubmed: 26883990
Ann Oncol. 2016 Aug;27(8):1612-9
pubmed: 27217544
J Bras Pneumol. 2018 Nov-Dec;44(6):505-509
pubmed: 30726327
Oncoimmunology. 2018 Aug 20;7(11):e1507262
pubmed: 30377569
Eur J Immunol. 2009 Sep;39(9):2492-501
pubmed: 19676072
Lancet Oncol. 2018 Mar;19(3):310-322
pubmed: 29449192
Nat Rev Clin Oncol. 2022 Dec;19(12):749-762
pubmed: 36207413
J Immunol. 2004 Jun 15;172(12):7306-14
pubmed: 15187106
J Thorac Oncol. 2016 Sep;11(9):1411-22
pubmed: 27296106
Immunol Rev. 2011 Nov;244(1):197-217
pubmed: 22017440
Nature. 2002 Jan 31;415(6871):536-41
pubmed: 11823861
Mayo Clin Proc. 2008 Mar;83(3):355-67
pubmed: 18316005
J Cancer Res Clin Oncol. 2022 Aug;148(8):1893-1901
pubmed: 35397688
PLoS One. 2012;7(2):e30676
pubmed: 22363469
Biomed Pharmacother. 2022 May;149:112898
pubmed: 35381448
J Exp Med. 2010 Sep 27;207(10):2187-94
pubmed: 20819927
Annu Rev Pathol. 2021 Jan 24;16:223-249
pubmed: 33197221
Int J Mol Sci. 2021 Jun 18;22(12):
pubmed: 34207126
Onco Targets Ther. 2019 May 29;12:4235-4244
pubmed: 31239702
Int J Infect Dis. 2021 May;106:142-154
pubmed: 33771672
Tumour Biol. 2016 Jan;37(1):619-25
pubmed: 26240025
Transl Lung Cancer Res. 2021 Feb;10(2):1029-1038
pubmed: 33718041
Lancet. 2021 Feb 13;397(10274):592-604
pubmed: 33581821
Lancet. 2019 May 4;393(10183):1819-1830
pubmed: 30955977
Immunity. 2001 Sep;15(3):445-55
pubmed: 11567634
Blood. 2005 Apr 1;105(7):2845-51
pubmed: 15591118
Gut. 2020 Oct;69(10):1867-1876
pubmed: 32759302
Eur J Immunol. 2002 Aug;32(8):2255-63
pubmed: 12209638
Oncologist. 2019 Aug;24(8):1128-1136
pubmed: 31015312
Immunol Rev. 2017 Mar;276(1):66-79
pubmed: 28258694
Cancers (Basel). 2020 May 14;12(5):
pubmed: 32422865
Immunotherapy. 2020 Jun;12(8):541-544
pubmed: 32345093
Transl Lung Cancer Res. 2016 Jun;5(3):288-300
pubmed: 27413711